Pain Management Therapeutics Market is Expected to Decline to USD 29.47 Billion Globally by 2018: Transparency Market Research

According to a new market report published by Transparency Market Research “Pain Management Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018,”in 2011, the global pain management therapeutics market was valued at USD 40.93 billion and is expected to decline at a CAGR of (5.5%) from 2012 to 2018, to reach an estimated value of USD 29.47 billion in 2018.

Browse the full report at http://www.transparencymarketresearch.com/pain-management-therapeutics.html

The global pain management therapeutics market is expected to experience a decline in revenues at a CAGR of (5.5%) during the forecast period, mainly due to patent expirations of the leading branded drugs. Although the global incidence rates of cancer, diabetes and other debilitating diseases that cause various chronic pain conditions is on a rise, the decline in market revenue is inevitable due to generic incursion for the top pain management drugs. Moreover, lack of a strong pipeline of novel or combination drugs that could help restore the positive growth of the overall market is also expected to contribute to the overall decline in the global pain management therapeutics market.

Administration of analgesics is the first line of treatment for the management of acute as well as chronic pain conditions. Some of the factors driving the growth of this market include the favorable regulatory and healthcare reforms such as the U.S. Patient Protection and Affordable Care Act of 2010. Also, the economic and effective nature of treatment with therapeutics compared to other modes, such as neurostimulation devices and acupuncture, will continue to fuel the uptake of drugs in pain management.

The market for non-steroidal anti-inflammatory drugs (NSAIDs) accounted for the largest share by revenue in 2011, of the total pain management therapeutics market by therapeutic class. This class comprises of some of the oldest known painkillers such as diclofenac, ibuprofen and Aspirin (acetylsalicylic acid) which are now commonly available as over-the-counter (OTC) medications, globally. However, the patent expiry of Celebrex (celecoxib) in 2013 is expected to negatively impact the market with a decline in revenues post patent expiry. The class of other non-narcotic analgesics consists of acetaminophen, sold as OTC drugs in the names of Tylenol, Panadol and Excedrin, and is expected to record the highest CAGR of 3.1% during the forecast period. Increase in the uptake of OTC drugs across the globe to overcome common pain conditions such as headache and body ache, will be responsible for this growth. The loss of patent exclusivity of other key brands such as Cymbalta (duloxetine), OxyContin (oxycodone) and Lidoderm (lidocaine) scheduled in the year 2013 will have a profound impact on the growth of the overall market.

North America was the largest regional market by revenue in 2011, due to the presence of one or more branded drugs belonging to each therapeutic class. However, the region is expected to record the lowest CAGR due to the looming patent expiries of these brands.

The market for generic formulations accounted for a larger share of the overall pain management therapeutics market in 2011, as against branded formulations. The market for branded pharmaceuticals was highly fragmented in 2011, with Pfizer, Inc., Purdue Pharma LP and Eli Lilly & Co. contributing to over 80% of the total market revenue. Other important players in this market include Endo Health Solutions, AstraZeneca PLC, Johnson & Johnson, and Merck & Co., Inc.

The pain management therapeutics market is segmented as follows:

Pain Management Therapeutics Market, by Therapeutic Class

·        Anticonvulsants

·        Antidepressants

·        Anesthetics

·        NSAIDs

·        Opioids

·        Other Non-Narcotic Analgesics (Acetaminophen)

·        Anti-Migraine Agents

Pain Management Therapeutics Market, by Indication

·        Neuropathic Pain

·        Fibromyalgia

·        Arthritic Pain, by Type

o   Osteoarthritis

o   Rheumatoid Arthritis

·        Chronic Back Pain

·        Migraine

·        Post-operative Pain

·        Cancer Pain

Pain Management Therapeutics Market, by Geography

·        North America

·        Europe

·        Asia-Pacific

·        Rest of the World (RoW)

About Us

TransparencyMarket Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Visit: http://www.transparencymarketresearch.com/

Browse the full report with TOC at 

http://www.transparencymarketresearch.com/pain-management-therapeutics.html

RFID Blood Monitoring Systems (Blood Refrigerators and Freezers) Market is Expected to Reach USD 174.2 Million Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research  “RFID Blood Monitoring Systems (Blood Refrigerators and Freezers) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global RFID blood refrigerators and freezers market was valued at USD 40.9 million in 2012 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 174.2 million in 2019.

Browse the full report at http://www.transparencymarketresearch.com/blood-monitoring-systems.html

The global RFID blood refrigerators and freezers market is expected to undergo rapid growth of 22.8% from 2013 to 2019. This growth is majorly attributed to the rapid adoption of RFID technology in the healthcare industry and growing need for efficient management of blood and blood products to minimize transfusion errors. Growing trend of consolidation of healthcare facilities has resulted in growth of their size. This is followed by the increase in the volume of inventory of blood and blood products. Consistency in the occurrence of transfusion and storage errors despite the use of bar-coding and note-taking systems also influence the demand for RFID blood tracking solutions in blood banks and hospitals.

The major concern for hospitals and blood centers is patient safety, minimal wastage of blood products and minimization of blood transfusion errors. Consistent prevalence of blood transfusion errors and to minimize the time consuming paperwork for inventory management, hospitals and blood banks throughout the world have begun to explore RFID tracking system for its potential in efficient inventory and supply management. Furthermore, privatization of healthcare infrastructure has led to a growth in the number of large sized blood banks and hospitals in many developing countries which require efficient catering to the transfusion needs of patients. This phenomenon serves as a potential opportunity for the RFID blood refrigerators and freezers manufacturers to introduce their products in these regions.

North America was the dominant geographical market for RFID blood refrigerators and freezers in 2012. RFID systems for Real Time Location Systems, asset tracking and inventory management are mature technologies in this region and many healthcare institutions have already adopted RFID to reduce errors and increase productivity. The US has the highest adoption rate of RFID in its healthcare system. The advanced healthcare system of this country and existence of large sized blood banks have been responsible for the high level of RFID tracking technology utilized in its healthcare infrastructure. Currently, North America encompasses more than 50% of the global RFID blood refrigerators and freezers market.

Moreover, the adoption of RFID blood refrigerators is high in blood banks than in hospital blood centers. This is due to the existence of more number of blood banks across all regions and the volume stored and supplied to and from blood banks is larger than that in hospital blood centers.

At present, the global market for RFID blood refrigerators and freezers has few players. Companies such as Biolog ID, Terso Solutions and Magellan technologies are the dominant players in this market. Recent FDA approval to the first RFID-enabled Blood tracking system will encourage more companies to enter this market thereby increasing the competition.

The global RFID blood refrigerators and freezers market is segmented as follows:

RFID Blood Refrigerators and Freezers Market, by Geography

·        North America

o     Hospital blood centers

o     Blood banks

·        Europe

o     Hospital blood centers

o     Blood banks

·        Asia-Pacific

o     Hospital blood centers

o     Blood banks

·        Rest of the World (RoW)

o     Hospital blood centers

o     Blood banks

Browse all Medical Devices Market Research Reports@ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Visit: http://www.transparencymarketresearch.com/

Global OSDF Excipients Demand is Expected to Reach 126.8 kilo tons in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research “Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market for Polymers (MCC, HPMC, CMC, Ethyl Cellulose, Povidone and Others), Alcohols (Glycerin, Sorbitol, Mannitol, Propylene Glycol), Minerals (Clay, Silicon Dioxide, Titanium Dioxide) and Sugars (Lactose, Sucrose) - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast, 2012 – 2018,” the global OSDF excipients demand was 93.8 kilo tons in 2011 and is expected to reach 126.8 kilo tons in 2018, growing at a CAGR of 4.5% from 2012 to 2018. In terms of revenue, the market was valued at USD 570.6 million in 2011 and is expected to reach USD 869.1 million in 2018, growing at a CAGR of 6.3% from 2012 to 2018. The overall pharmaceutical excipients demand was 519.5 kilo tons in 2011 and is expected to reach 685.6 kilo tons in 2018, growing at a CAGR of 4.1% from 2012 to 2018.

Browse the full report at http://www.transparencymarketresearch.com/pharma-excipient-market.html

The growth of the global pharmaceutical market on account of increasing aging population particularly in countries such as U.S. and Japan coupled with the development and introduction of new excipients which exhibit improved properties such as flowability is expected to drive excipients demand over the next five years. However, high costs of manufacturing, stringent government approval process and shortage of approved sites by the Food and Drug Administration (FDA) are expected to hamper the growth of this market.

Polymers were the largest consumed product segment for overall and OSDF excipients market and accounted for over 30% of the global market in both forms. Sugar and other excipient products are expected to witness the fastest growth rate over the forecast period. Within the mineral excipients market, calcium phosphate and calcium carbonate are expected to dominate the market over the next six years. Lactose and sucrose forms of sugar excipients are expected to be the key market segments over the next few years.

Consumption of overall excipients was highest in Europe accounting for approximately 160 kilo tons in 2011. Demand for OSDF excipients was also highest from Europe accounting for over 30% of the total volume in 2011. However, the highest demand for Overall and OSDF excipients is expected from Asia Pacific due to the growth of the medical and food industry. In addition, increasing aging population in countries such as China and Japan are expected to contribute to the demand for excipients.

Some of the key participants profiled in the report include AkzoNobel, BASF, Cargill, Croda International Plc, Dow Chemical Company, Eastman Chemical Company, Evonik, Innophos Holdings Inc., The Lubrizol Corporation and Royal Dutch Shell Plc among others.

The report gives a comprehensive view of the excipients market in terms of volume and revenue. In addition, the report includes the demand forecast for each product type, based on volume and revenue. The report comprises the following segments:

Global Overall and OSDF Excipients Market: Product Segment Analysis

§  Polymers

§  Alcohols

§  Minerals

§  Gelatin

§  Sugar and Others

The report further segments the Overall and OSDF excipients product segments as:

Global Overall and OSDF Polymer Excipients Market: Product Segment Analysis

§  MCC

§  HPMC

§  Ethyl Cellulose

§  Methyl Cellulose

§  CMC

§  Croscarmellose Sodium

§  Povidone

§  Pregelatinized starch

§  Sodium starch glycolate

§  Polyethylene Glycol

§  Acrylic Polymers

Global Overall and OSDF Alcohol Excipients Market: Product Segment Analysis

§  Glycerin

§  Propylene Glycol

§  Sorbitol

§  Mannitol

§  Others

Global Overall and OSDF Alcohol Excipients Market: Product Segment Analysis

§  Calcium Phosphate

§  Calcium Carbonate

§  Clay

§  Silicon Dioxide

§  Titanium Dioxide

§  Others

Global Overall and OSDF Sugar and Other Excipients Market: Product Segment Analysis

§  Lactose

§  Sucrose

§  Others

The report provides a cross-sectional analysis of Overall and OSDF excipients with respect to the following regions:

§  North America

§  Europe

§  Asia Pacific

§  Rest of the World

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Visit: http://www.transparencymarketresearch.com/

Browse the full report with TOC at http://www.transparencymarketresearch.com/pharma-excipient-market.html

China’s efforts in placing a nationwide smoking ban by end of the year 2014

In an effort to reduce tobacco products, China – being the world’s biggest consumers of tobacco desires to put an end to the nation-wide ban on smoking in open public places.

The National Health and Family Planning Commission in China is highly concerned about the nearly growing 300 million smokers in the country, and thus, continues to pressurize the lawmakers to lay down stricter laws on using tobacco in public places as well as in the country, said the Reuters.

The commission has recommended different options for reducing the use of tobacco. This includes banning smoking in all schools and hospitals, and seeking more education on the threats and dangers of tobacco around us. According to the Reuters, smoking has taken a major toll on the Chinese health as it is used in most of the essential places of the society and socializing events.

As compared to the sheer damage that smoking causes in humans, tobacco’s economic advantages are critical and trivial, said Mao Qun'an, a spokesman for the commission at a news conference.  

Many experts in China tried to minimize the use of tobacco in the country, but the country’s powerful tobacco industry mired the respective measures by placing health warning s and not permitting tobacco prices. The government circulars requested the government officials to avoid smoking in public places. According to the Reuters, this was the best example set by the government.

A nationwide ban has been effectuated in China on a very serious scale, and furthermore, places like Beijing began this prohibition of smoking in public venues and different government offices. However, the lack of enforcing the ban has not affected China’s goal in reducing smoking though. There are many people in the country who still ignore the signs of ban on smoking in public places.

Short-Term ARV benefits during early HIV Infection

Taking short courses of antiretrovirals (ARVs) during the primary, or early, HIV infection (PHI) stages provide immunological benefits for at least a year after breaking the rhythm of the treatment, reported aidsmap.

These findings were published in PLOS ONE, whereby, a group of researchers conducted a meta-analysis of nearly eight studies of treatment taking place during the PHI. This resulted in both, a control arm and a treatment.

Moreover, the medical studies that were published between the phases 2004 and 2012 consisted of cohorts spanning from 11 to 822 participants. They took the courses for between 12 and 86 weeks, followed by nine months and six years after the intermittent treatment.

Nonetheless, a year after stalling the ARV treatment, those who had an early treatment witnessed a minimum increase of 86 CD4 cells, and had their viral load resulted into half its value. This was compared to the control group. And the ones who received their treatment experienced lower CD4 counts and viral load measurements.

When the researchers analyzed the data, they found that the benefits of early treatment were far lower than the regular, but after adjusting the results, they examined even greater benefits to the early treatment.

The early treatment was mainly beneficial to those who had begun at lower CD4s but at a higher viral load. 

Chip Maker Intel Vows to Avoid Sourcing ‘Conflict Minerals’

After the concept of sourcing ‘conflict free’ diamonds and metals has gained popularity the world over, globally leading chip maker Intel has now taken a pledge to support this cause. Intel recently announced at the CES in Las Vegas that it has pledged to refrain from sourcing raw material such as minerals from the company’s factories that are located in areas that predominantly witness human rights being abused.

The manufacturing process of computer chips relies heavily on elements such as tungsten, gold, and silver. However, these metals are typically sourced (mined and smelted) from countries where human rights violations are a major cause of concern. These countries include the Democratic Republic of the Congo (DRC). In these regions, workers are subjected to poor treatment and the profits earned from operations here are typically used for funding armed conflicts among local factions that fight to gain a larger share in the mineral mining business here.

According to human rights experts, violent acts of abuse have mostly been noted in the conflicts that are carried out to gain control of the mineral wealth that abounds in this region.

Just six months into his job as the chief executive of Intel, Brian Krzanich announced at the CES that though the company considers minerals an important part of the chip making process, the people engaged in mining these minerals are far more important.

The United Nations Security Council Committee had, in a recent report stated that electronics products are often carriers of ‘conflict minerals’.

Krzanich further added that the company has taken the step to avoid sourcing ‘conflict minerals’ as it is concerned about the potential impact that could be caused by these problems on the supply chain. The company’s final decision comes after a complete audit of its supply chain. 

World Bank Considers India’s Solar Power Projects Lucrative

This could well be the boost that the Indian solar power industry needed to emerge as a leader on the global scenario. The World Bank considers the country’s Jawaharlal Nehru National Solar Mission 2010 a project that’s “well-poised” to help India gain the definitive tag of a global leader in solar power development. The mission was set up with the goal of installing 20 GW of solar power by the end of 2020. In 2010, the installed solar capacity was just 30MW and it grew to a whopping 2,000 MW in 2013.

These are the observations of a report titled “Paving the Way for a Transformational Future: Lessons from JNNSM Phase 1” that was released by the World Bank. The report states that the widespread growth and utilization of solar power can help reduce India’s current dependence on imported fuel. Further, it can also curtail emissions of greenhouse gas and help contribute to India’s energy security.

The WB is particularly impressed by the fact that India has made unprecedented progress in developing solar power over a period of three years, proving that it is in a position to make optimum utilization of solar power that is abundantly available in this country. The efficient and effective use of solar power can help the country address its power shortage; it can change the lives of millions of Indians who do not currently have access to power. This would potentially immensely contribute to the cause of economic development.

Looking at the success story of Phase I of the Mission, the World Bank is now in talks with the ministry of new and renewable energy to possible finance solar projects. Funds to the tune of around $13 billion are currently required with the debt requirement component being as high as $9 billion. If things go to plan, it is believed that the World Bank could partially finance the debt component.